Confirmed cases of RR-/MDR-TB
Filters
Confirmed cases of RR-/MDR-TB
China, Hong Kong Special Administrative Region
Confirmed cases of RR-/MDR-TB
20052024
RR-/MDR-TB confirmed cases by country in 2024 (confirmed cases of RR-/MDR-TB)
In 2024, India had the highest value (55,447) among 176 countries.
| # | Country | Value | Change |
|---|---|---|---|
| 1 | India | 55,447 | -14.2% |
| 1 | United States of America (2023) | 133 | +20.9% |
| 2 | Russian Federation | 22,807 | -11.8% |
| 2 | Japan (2023) | 58 | -10.8% |
| 3 | China | 15,255 | +2.3% |
| 3 | Nicaragua (2023) | 52 | +36.8% |
Similar Datasets
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
WHO (TB_rdst_num_prct)
Standards and benchmarks for TB and vital registration system surveillance
WHO (TB_sb)
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
WHO (TB_rdst_num)
Transgender: Condom use (percent)
WHO (TG_CONDOMUSE_PERCENT)